Vozmozhnosti primeneniya kombinirovannykh oral'nykh kontratseptivov u bol'nykh genital'nym endometriozom


Cite item

Full Text

Abstract

References

  1. Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364: 1789-99.
  2. Cramer DW, Missmer SA. The epidemiology of endometriosis. Ann NY Acad Sci 2002; 955: 11-22; discussion 34-6, 396-406.
  3. Bulun SE. Endometriosis. N Engl J Med 2009; 360: 268-79.
  4. Bishoff F, Heard M, Simpson J. Somatic DNA alterations in endometriosis: High frequency of chromosome 17 and p53 loss in late stage endometriosis. J Reprod Immunol 2002; 55: 49-64.
  5. Lebovic D, Baldocchi RA, Mueller MD et al. Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses. Fertil Steril 2002; 78: 849-54.
  6. Sinaii N, Cleary SD, Ballweg ML et al. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic disease among women with endometriosis: a survey analysis. Hum reprod 2002; 17: 2715-22.
  7. Grahame-Smith DG, Aronson JK. Oxford Textbook of Clinical Pharmacology and Drug Therapy. 3rd Edition. Oxford: Oxford University Press, 2002.
  8. Osteen K, Bruner-Tran K, On D et al. Paracrine mediators of endometrial matrix metalloproteinase expression: Potential targets for progestin-based treatment of endometriosis. Ann NY Acad Sci 2002; 955: 139-46.
  9. Адамян Л.В., Зайратьянц О.В., Осипова А.А. и др. Роль пролиферации и апоптоза в патогенезе генитального эндометриоза. Спец. выпуск. 3-й Междунар. науч. конгресс «Новые технологии в акушерстве и гинекологии» 2007; с. 123-4.
  10. Meresman GF, Augé L, Barañao RI et al. Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 2002; 77: 1141-7.
  11. Van Kaam KJAF, Romano A, Schouten JP et al. Progesterone receptor polymorphism +331G/A is associated with a decreased risk of deep infiltrating endometriosis. Hum reprod 2007; 22 (1): 129-35.
  12. Arruda MS, Petta CA, Abrao MS, Benetti-Pinto CL. Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women. Hum Reprod 2003; 18: 756-9.
  13. Husby GK, Haugen RS, Moen MH. Diagnostic delay in women with pain and endometriosis. Acta Obstet Gynecol Scand 2003; 82: 649-53.
  14. Vicino M, Scioscia M, Resta L et al. Fibrotic tissue in the endometrioma capsule: surgical and physiopathologic consideration from histologic findings. Fertil Steril 2009; 91: 1326-8.
  15. Schweppe K.-W. Long-term use of progestogens - effects on endometriosis, adenomiosis and myomas. Gynecol Endocrinol 2007; 23 (S1): 17-21.
  16. Petta CA, Ferriani RA, Abrao MS et al. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRG analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005; 20: 1993-8.
  17. Wong YK, Tang CH. Levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena) vs depot medroxyprogesterone acetate (MPA, Depoprovera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomized controlled trial. The 11th World Congress on controversies in obstetrics, gynecology and infertility. Paris, 2008; с. 44A.
  18. Momoeda M, Harada T, Terakawa N et al. Long-term use of dienogest for the treatment of endometriosis. J Obstet Gynaecol Res 2009; 35: 1069-76.
  19. Prentice A, Deary AJ, Bland E. Progestagens and anti-progestagens for pain associated with endometriosis (Cochrane Review) 2003; In the Cochrane Library, Oxford, Issue 1. Oxford: Update Software.
  20. Moore J, Kennedy S, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis (Cochrane Review) 2003; In the Cochrane Library, Oxford, Issue 1. Oxford: Update Software.
  21. Vercellini P, Pietropaolo G, Di Georgi O et al. Treatment of symptomatic rectovaginal endometriosis with an estrogen-progestogen combination versus low-dose norethindrone acetate. Fertil Steril 2005; 84: 1375-87.
  22. Vercellini P, Somigliana E, Vigano P et al. Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 2008; 22: 275-306.
  23. Vercellini P, De Giorgi O, Mosconi P et al. Cyproterone acetate versus a continuous monophasic oral contraceptive in the treatment of recurrent pelvic pain after conservative surgery for symptomatic endometriosis. Fertil Steril 2002; 77: 52-61.
  24. Fu L, Osuga Y, Hirata T et al. Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells. Fertil Steril 2008; 89: 1344-7.
  25. Horie S, Harada T, Mitsunari M et al. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertil Steril 2005; 83: 1533-35.
  26. Vercellini P, Barbara G, Somigliana E et al. Comparison of contraceptive ring and patch for the treatment of symptomatic endometriosis. Fertil Steril 2009.
  27. Галустян С.А., Белкина Н.В., Галустян В.С., Крутова В.А. Лечение наружного генитального эндометриоза препаратом «Жанин». Современные проблемы науки и образования. 2008 (Прил. 1); 11: 180-2.

Copyright (c) 2012 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-63961 от 18.12.2015.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies